🇺🇸 FDA
Patent

US 6410023

Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of a non-essential gene

expired A61KA61K2039/522A61K39/00

Quick answer

US patent 6410023 (Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of a non-essential gene) held by The United States of America expires Mon Jun 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America
Grant date
Tue Jun 25 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
53
CPC classes
A61K, A61K2039/522, A61K39/00, A61P, A61P31/16